NASDAQ:EXAC - Exactech Stock Price, Price Target & More

$49.25 0.00 (0.00 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$49.25

Today's Range$49.25 - $49.30

52-Week Range$23.75 - $50.95

Volume256,300 shs

Average Volume182,742 shs

Market Capitalization$707.53 million

P/E RatioN/A

Dividend YieldN/A

Beta0.9

About Exactech (NASDAQ:EXAC)

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive EXAC News and Ratings via Email

Sign-up to receive the latest news and ratings for EXAC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryHealth Care Equipment

SectorN/A

SymbolNASDAQ:EXAC

CUSIP30064E10

Webwww.exac.com

Phone+1-352-3771140

Debt

Debt-to-Equity Ratio0.06%

Current Ratio4.08%

Quick Ratio2.09%

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio37.88

P/E Growth3.66

Sales & Book Value

Annual Sales$257.57 million

Price / Sales2.76

Cash Flow$2.5413 per share

Price / Cash19.38

Book Value$16.51 per share

Price / Book2.98

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$160,000.00

Net Margins4.72%

Return on Equity4.62%

Return on Assets3.82%

Miscellaneous

Employees733

Outstanding Shares14,420,000

How to Become a New Pot Stock Millionaire

Exactech (NASDAQ:EXAC) Frequently Asked Questions

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

How were Exactech's earnings last quarter?

Exactech, Inc. (NASDAQ:EXAC) announced its quarterly earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to analyst estimates of $61.78 million. Exactech had a net margin of 4.72% and a return on equity of 4.62%. View Exactech's Earnings History.

What price target have analysts set for EXAC?

3 brokerages have issued 1-year price objectives for Exactech's shares. Their predictions range from $49.00 to $49.00. On average, they anticipate Exactech's share price to reach $49.00 in the next year. View Analyst Ratings for Exactech.

Who are Exactech's key executives?

Exactech's management team includes the folowing people:

R. William Petty M.D., Executive Chairman of the Board (Age 74)
David W. Petty, Chief Executive Officer, President and Director (Age 50)
Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer (Age 49)
Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division (Age 59)
Gary J. Miller Ph.D., Executive Vice President - Research and Development (Age 69)
Donna M. Edwards, Vice President, Legal and General Counsel (Age 44)
Betty A. Petty, Vice President - Administration, Corporate Secretary (Age 74)
James G. Binch, Independent Director (Age 69)
W. Andrew Krusen Jr., Independent Director (Age 68)
William B. Locander Ph.D., Independent Director (Age 73)

Has Exactech been receiving favorable news coverage?

News coverage about EXAC stock has trended somewhat positive on Thursday, according to Accern. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Exactech earned a media sentiment score of 0.10 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 46.64 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Exactech?

Shares of EXAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactech's stock price today?

One share of EXAC stock can currently be purchased for approximately $49.25.

How big of a company is Exactech?

Exactech has a market capitalization of $707.53 million and generates $257.57 million in revenue each year. Exactech employs 733 workers across the globe.

How can I contact Exactech?

Exactech's mailing address is 2320 NW 66th Ct, GAINESVILLE, FL 32653-1630, United States. The medical equipment provider can be reached via phone at +1-352-3771140 or via email at [email protected]

MarketBeat Community Rating for Exactech (EXAC)

Community Ranking:		2.2 out of 5 ( )
Outperform Votes:		126 (Vote Outperform)
Underperform Votes:		166 (Vote Underperform)
Total Votes:		292

MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe EXAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Exactech (NASDAQ:EXAC) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

3 Wall Street analysts have issued ratings and price targets for Exactech in the last 12 months. Their average twelve-month price target is $49.00, suggesting that the stock has a possible downside of 0.51%. The high price target for EXAC is $49.00 and the low price target for EXAC is $49.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.00	2.00	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$49.00	$49.00	$49.00	$42.00
Price Target Upside:	0.51% downside	3.07% downside	3.07% downside	0.36% upside

Exactech (NASDAQ:EXAC) Consensus Price Target History

Price Target History for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ:EXAC) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
12/7/2017	Robert W. Baird	Reiterated Rating	Hold	$49.00	Low
10/24/2017	Gabelli	Downgrade	Buy -> Hold		N/A
10/23/2017	Sidoti	Downgrade	Buy -> Neutral		N/A

(Data available from 4/26/2016 forward)

Exactech (NASDAQ:EXAC) Earnings History and Estimates Chart

Earnings by Quarter for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ:EXAC) Earnings Estimates

Current Year EPS Consensus Estimate: $1.3 EPS
Next Year EPS Consensus Estimate: $1.4 EPS

Exactech (NASDAQ EXAC) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/30/2017	Q3 2017	$0.23	$0.20	$61.78 million	$61.40 million	View	N/A
7/27/2017	Q2 2017	$0.33	$0.33	$67.75 million	$67.30 million	View	N/A
4/25/2017	Q1 2017	$0.31	$0.34	$67.05 million	$69.48 million	View	N/A
2/21/2017	Q416	$0.32	$0.34	$66.00 million	$66.20 million	View	Listen
10/31/2016	Q316	$0.22	$0.22	$58.69 million	$59.90 million	View	N/A
8/1/2016	Q216	$0.30	$0.31	$64.18 million	$66.10 million	View	N/A
4/26/2016	Q116	$0.29	$0.31	$63.63 million	$65.30 million	View	N/A
2/16/2016	Q415	$0.28	$0.29	$61.29 million	$62.70 million	View	Listen
10/27/2015	Q315	$0.23	$0.20	$58.46 million	$56.20 million	View	Listen
7/28/2015	Q215	$0.27	$0.26	$62.13 million	$61.50 million	View	Listen
4/28/2015	Q115	$0.30	$0.29	$63.71 million	$61.40 million	View	N/A
2/17/2015	Q414	$0.33	$0.36	$63.30 million	$63.30 million	View	N/A
10/21/2014	Q314	$0.25	$0.21	$58.60 million	$57.90 million	View	N/A
7/28/2014	Q214	$0.30	$0.30	$63.80 million	$63.92 million	View	N/A
4/21/2014	Q114	$0.29	$0.30	$63.05 million	$63.30 million	View	N/A
2/19/2014	Q413	$0.31	$0.33	$63.20 million	$61.60 million	View	N/A
10/22/2013	Q313	$0.21	$0.23	$55.36 million	$55.70 million	View	N/A
7/23/2013	Q2 2013	$0.25	$0.27	$58.42 million	$60.60 million	View	N/A
4/23/2013	Q1 2013	$0.29	$0.29	$61.63 million	$59.30 million	View	N/A
2/26/2013	Q4 2012	$0.28	$0.29	$58.20 million	$59.30 million	View	N/A
10/30/2012	Q312	$0.17	$0.19	$50.20 million	$51.30 million	View	N/A
7/31/2012		$0.23	$0.23			View	N/A
5/1/2012		$0.23	$0.25			View	N/A
2/28/2012		$0.25	$0.18			View	N/A
11/1/2011		$0.20	$0.15			View	N/A
8/2/2011		$0.26	$0.28			View	N/A
5/3/2011		$0.27	$0.28			View	N/A
2/28/2011		$0.23	$0.23			View	N/A
11/2/2010	Q3 2010	$0.21	$0.12			View	N/A
8/3/2010	Q2 2010	$0.24	$0.25			View	N/A
4/27/2010	Q1 2010	$0.23	$0.26			View	N/A
2/22/2010	Q4 2009	$0.23	$0.25			View	N/A
10/27/2009	Q3 2009	$0.18	$0.25			View	N/A
7/28/2009	Q2 2009	$0.25	$0.26			View	N/A
4/29/2009	Q1 2009	$0.21	$0.26			View	N/A
2/18/2009	Q4 2008	$0.21	$0.26			View	N/A
10/28/2008	Q3 2008	$0.15	$0.16			View	N/A
7/30/2008	Q2 2008	$0.23	$0.24			View	N/A
4/29/2008	Q1 2008	$0.20	$0.21			View	N/A
2/28/2008	Q4 2007	$0.23	$0.23			View	N/A

(Earnings results data provided by Zacks Investment Research)

Exactech (NASDAQ:EXAC) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Exactech (NASDAQ EXAC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 61.22%

Insider Trading History for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ EXAC) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2017	Fern Watts	Director	Sell	1,013	$29.04	$29,417.52	4,727
8/4/2017	James G Binch	Director	Sell	747	$28.40	$21,214.80	3,554
5/31/2017	William B Locander	Director	Sell	988	$30.34	$29,975.92	8,555
5/23/2017	Joel C Phillips	CFO	Sell	7,610	$30.71	$233,703.10	99,907
3/9/2017	Fern Watts	Director	Sell	1,000	$24.25	$24,250.00	5,101
3/8/2017	James G Binch	Director	Sell	3,588	$24.16	$86,686.08	6,850
3/1/2017	William B Locander	Director	Sell	1,823	$24.52	$44,699.96	7,801
2/24/2017	Bruce E Thompson	SVP	Sell	4,906	$24.77	$121,521.62	27,937
11/3/2016	James G Binch	Director	Sell	600	$22.61	$13,566.00	5,682
8/25/2016	Fern Watts	Director	Sell	1,100	$27.68	$30,448.00	4,936
8/22/2016	Bruce E Thompson	SVP	Sell	1,433	$27.97	$40,081.01	25,375
8/19/2016	David W Petty	CEO	Sell	3,550	$27.75	$98,512.50	63,122
7/1/2016	Joel C Phillips	CFO	Sell	3,000	$26.75	$80,250.00	101,632
6/8/2016	Gary J Miller	EVP	Sell	9,800	$25.16	$246,568.00	30,914
6/7/2016	Bruce E Thompson	SVP	Sell	2,000	$25.07	$50,140.00	25,647
6/3/2016	James G Binch	Director	Sell	600	$24.86	$14,916.00	5,585
6/2/2016	Gary J Miller	EVP	Sell	3,381	$25.11	$84,896.91	30,914
5/25/2016	Gary J Miller	EVP	Sell	9,319	$25.10	$233,906.90	30,914
5/18/2016	Gary J Miller	EVP	Sell	9,664	$24.37	$235,511.68	30,914
5/9/2016	Joel C Phillips	CFO	Sell	3,900	$23.13	$90,207.00	100,632
5/5/2016	James G Binch	Director	Sell	1,870	$23.00	$43,010.00	5,400
5/3/2016	Fern Watts	Director	Sell	2,000	$22.76	$45,520.00	6,251
4/29/2016	Betty A Petty	VP	Sell	18,000	$22.65	$407,700.00	70,400
4/27/2016	Gary J Miller	EVP	Sell	9,851	$24.06	$237,015.06	30,914
4/26/2016	Gary J Miller	EVP	Sell	7,985	$23.11	$184,533.35	30,914
4/25/2016	Gary J Miller	EVP	Sell	4,725	$23.14	$109,336.50	30,914
3/31/2016	Gary J Miller	EVP	Sell	7,000	$19.95	$139,650.00	30,914
3/10/2016	Joel C Phillips	CFO	Sell	2,000	$18.58	$37,160.00	104,226
3/8/2016	Betty A Petty	VP	Sell	15,964	$19.06	$304,273.84	79,627
3/7/2016	Donna M Edwards	VP	Sell	10,000	$18.85	$188,500.00	19,795
3/3/2016	Gary J Miller	EVP	Sell	7,017	$19.23	$134,936.91	37,914
3/3/2016	William B Locander	Director	Sell	2,435	$19.25	$46,873.75	4,866
12/10/2015	James G Binch	Director	Sell	1,500	$17.03	$25,545.00	7,232
12/9/2015	Fern Watts	Director	Sell	1,200	$17.32	$20,784.00	6,213
12/1/2015	Bruce E. Thompson	SVP	Sell	21,904	$17.57	$384,853.28	23,139
11/24/2015	Bruce E. Thompson	SVP	Sell	900	$17.75	$15,975.00	23,139
9/1/2015	Bruce E. Thompson	SVP	Sell	2,107	$19.45	$40,981.15	22,780
5/28/2015	Joel C Phillips	CFO	Sell	5,000	$21.76	$108,800.00
5/20/2015	William B Locander	Director	Sell	3,350	$21.50	$72,025.00
5/18/2015	Fern Watts	Director	Sell	2,200	$21.21	$46,662.00
5/4/2015	Joel C Phillips	CFO	Sell	2,700	$21.67	$58,509.00
3/20/2015	Gary J Miller	EVP	Sell	32,800	$24.95	$818,360.00
2/24/2015	R William Petty	Chairman	Sell	45,067	$23.08	$1,040,146.36
2/2/2015	Betty A Petty	VP	Sell	7,500	$20.74	$155,550.00
1/8/2015	Gary J Miller	EVP	Sell	4,145	$23.17	$96,039.65
12/3/2014	Gary J Miller	EVP	Sell	5,000	$21.83	$109,150.00
11/25/2014	Betty A Petty	Major Shareholder	Sell	12,500	$21.86	$273,250.00
11/25/2014	Bruce E Thompson	SVP	Sell	6,500	$22.05	$143,325.00
10/31/2014	Joel C Phillips	CFO	Sell	5,000	$21.44	$107,200.00
9/5/2014	R William Petty	Major Shareholder	Sell	25,000	$23.68	$592,000.00
8/25/2014	Albert H Burstein	Director	Sell	8,852	$23.73	$210,057.96
7/1/2014	Gary J Miller	EVP	Sell	12,392	$26.21	$324,794.32
6/26/2014	Gary J Miller	EVP	Sell	1,894	$25.06	$47,463.64
6/25/2014	Gary J Miller	EVP	Sell	16,356	$25.33	$414,297.48
6/10/2014	Joel C Phillips	CFO	Sell	5,000	$24.77	$123,850.00
6/5/2014	Bruce E Thompson	SVP	Sell	1,667	$23.50	$39,174.50
6/5/2014	Joel C Phillips	CFO	Sell	5,000	$23.21	$116,050.00
5/29/2014	Bruce E Thompson	SVP	Sell	1,588	$23.00	$36,524.00
5/12/2014	David Petty	CEO	Sell	10,287	$20.99	$215,924.13	69,253
5/8/2014	David Petty	CEO	Sell	7,976	$21.51	$171,563.76	67,516
4/24/2014	Bruce Thompson	SVP	Sell	2,412	$23.78	$57,357.36	16,241
4/23/2014	William Locander	Director	Sell	4,500	$23.18	$104,310.00	3,724
2/28/2014	William Locander	Director	Sell	1,819	$23.16	$42,128.04	8,224
12/5/2013	R William Petty	CEO	Sell	10,000	$23.67	$236,700.00	99,400
11/12/2013	Bruce Thompson	SVP	Sell	3,079	$23.35	$71,894.65	18,074
8/22/2013	William Locander	Director	Sell	1,521	$19.05	$28,975.05	7,640
7/15/2013	Gary J Miller	EVP	Sell	10,250	$20.07	$205,717.50
7/8/2013	Gary J Miller	EVP	Sell	1,000	$20.00	$20,000.00
6/17/2013	Gary J Miller	EVP	Sell	8,125	$18.98	$154,212.50
6/5/2013	R William Petty	CEO	Sell	3,885	$18.00	$69,930.00
6/4/2013	R William Petty	CEO	Sell	14,257	$18.01	$256,768.57
5/28/2013	R William Petty	CEO	Sell	20,000	$18.21	$364,200.00
5/22/2013	R William Petty	CEO	Sell	11,493	$18.13	$208,368.09
5/17/2013	R William Petty	CEO	Sell	17,472	$18.05	$315,369.60
5/16/2013	R William Petty	CEO	Sell	22,893	$18.22	$417,110.46
5/9/2013	R William Petty	CEO	Sell	10,000	$18.25	$182,500.00
5/8/2013	David W Petty	President	Sell	8,000	$18.35	$146,800.00
12/4/2012	R William Petty	CEO	Sell	14,048	$16.29	$228,841.92

(Data available from 1/1/2013 forward)

Exactech (NASDAQ EXAC) News Headlines

Source:

Date	Headline
	Exactech, Inc. (EXAC) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 7:24 PM
	Exactech (EXAC) Lowered to Sell at BidaskClub www.americanbankingnews.com - April 14 at 11:25 PM
	Robert W. Baird Analysts Give Exactech (EXAC) a $34.00 Price Target www.americanbankingnews.com - April 7 at 12:48 PM
	Exactech (EXAC) Rating Lowered to Hold at Gabelli www.americanbankingnews.com - April 5 at 9:00 PM
	Exactech Knee Research Honored with Orthopaedic Research Society’s Best Implant Poster Award www.bizjournals.com - April 3 at 4:29 PM
	Comparing Covidien (COV) & Exactech (EXAC) www.americanbankingnews.com - March 28 at 7:18 PM
	Exactech (EXAC) vs. Asante Solutions (PUMP) Critical Analysis www.americanbankingnews.com - March 27 at 1:39 AM
	BidaskClub Lowers Exactech (EXAC) to Strong Sell www.americanbankingnews.com - March 26 at 2:30 PM
	Exactech (EXAC) Rating Increased to Hold at BidaskClub www.americanbankingnews.com - March 25 at 3:12 PM
	63,624 Shares in Exactech, Inc. (EXAC) Purchased by Koch Industries Inc. www.americanbankingnews.com - March 5 at 3:42 PM
	Martingale Asset Management L P Sells 30,602 Shares of Exactech, Inc. (EXAC) www.americanbankingnews.com - March 4 at 12:50 PM
	Kennedy Capital Management Inc. Takes Position in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 3 at 3:30 PM
	Exactech, Inc. (EXAC) Shares Sold by Royce & Associates LP www.americanbankingnews.com - March 3 at 9:12 AM
	Water Island Capital LLC Acquires New Holdings in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 2 at 9:38 PM
	Spark Investment Management LLC Lowers Position in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 1 at 6:50 PM
	Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - February 27 at 9:30 PM
	Harvest Management LLC Invests $3.23 Million in Exactech, Inc. (EXAC) www.americanbankingnews.com - February 27 at 3:00 PM
	K2 Principal Fund L.P. Invests $5.02 Million in Exactech, Inc. (EXAC) Stock www.americanbankingnews.com - February 26 at 3:12 PM
	With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry? finance.yahoo.com - February 19 at 9:03 AM
	BidaskClub Lowers Exactech (EXAC) to Sell www.americanbankingnews.com - February 17 at 11:00 PM
	Exactech (EXAC) Gets Acquired by TPG Capital, Goes Private www.zacks.com - February 15 at 8:46 AM
	Exactech Announces Completion of Merger with TPG Capital finance.yahoo.com - February 14 at 4:47 PM
	Exactech (EXAC) Scheduled to Post Quarterly Earnings on Monday www.americanbankingnews.com - February 12 at 3:02 AM
	Critical Contrast: NuVasive (NUVA) versus Exactech (EXAC) www.americanbankingnews.com - February 12 at 1:16 AM
	Exactech, Inc. (EXAC) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - February 2 at 9:24 PM
	Exactech (EXAC) & Palomar Medical Technologies (PMTI) Critical Analysis www.americanbankingnews.com - January 29 at 1:12 AM
	Osteon Merger Sub, Inc. -- Moody's assigns B2 Corporate Family Rating to acquirer of Exactech finance.yahoo.com - January 25 at 9:08 AM
	Exactech (EXAC) Cut to Sell at BidaskClub www.americanbankingnews.com - January 20 at 10:28 AM
	The Europe Shoulder Arthroplasty Market would witness market growth of 7.5% CAGR during the forecast period (2017 - 2023) www.bizjournals.com - January 11 at 9:47 AM
	Exactech, Inc. :EXAC-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 finance.yahoo.com - January 1 at 9:25 AM
	The Global Shoulder Arthroplasty Market is expected to reach $ 1,866.3 million by 2023 www.bizjournals.com - December 29 at 5:17 PM
	LAWSUIT ALERT – Andrews & Springer LLC Announces That A Securities Class Action Has Been Filed Against Exactech, Inc. - EXAC finance.yahoo.com - December 28 at 3:03 PM
	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC finance.yahoo.com - December 28 at 3:03 PM
	Exactech (EXAC) Upgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - December 26 at 9:52 PM
	Comparing Zimmer Biomet (ZBH) and Exactech (EXAC) www.americanbankingnews.com - December 24 at 12:40 AM
	EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc. finance.yahoo.com - December 21 at 9:28 AM
	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC finance.yahoo.com - December 15 at 5:57 PM
	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Exactech, Inc. (EXAC) www.prnewswire.com - December 15 at 10:33 AM
	Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - December 14 at 11:32 PM
	EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc. finance.yahoo.com - December 14 at 9:35 AM
	EXACTECH MERGER INVESTIGATION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Exactech, Inc. feeds.benzinga.com - December 13 at 8:33 PM
	ETFs with exposure to Exactech, Inc. : December 7, 2017 finance.yahoo.com - December 7 at 5:48 PM
	Exactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System finance.yahoo.com - December 7 at 5:48 PM
	Exactech's (EXAC) Hold Rating Reaffirmed at Robert W. Baird www.americanbankingnews.com - December 7 at 7:56 AM
	Wall Street's M&A Chatter From December 4: Prysmian-General Cable, Exactech-TPG Capital, TTM Technologies-Anaren www.benzinga.com - December 5 at 10:09 AM
	Exactech (EXAC), TPG Capital Amend Merger Agreement Providing for Increase in Consideration to $49.25/Share www.streetinsider.com - December 5 at 10:09 AM
	BRIEF-Exactech And TPG Capital Announce Amended Merger Agreement With Increase In Merger Consideration To $49.25 Per Share www.businessinsider.com - December 5 at 10:09 AM
	Exactech Inc. (EXAC) Jumped To A New High After Amended Merger Agreement www.rttnews.com - December 5 at 10:09 AM
	Exactech gets higher $737 million cash offer from TPG Capital www.reuters.com - December 5 at 10:09 AM
	ACT NOW: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC finance.yahoo.com - December 4 at 5:20 PM

Exactech (NASDAQ:EXAC) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Exactech (NASDAQ:EXAC) Income Statement, Balance Sheet and Cash Flow Statement

Exactech (NASDAQ EXAC) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff